A study analysing efficacy and safety and change in skeletal muscle area and total fat-free mass in patients with BRAF-mutant metastatic malignant melanoma
Latest Information Update: 11 Aug 2021
At a glance
- Drugs Cobimetinib (Primary) ; Dabrafenib (Primary) ; Trametinib (Primary) ; Vemurafenib (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 11 Aug 2021 New trial record